XML 134 R120.htm IDEA: XBRL DOCUMENT v3.24.0.1
PARENT COMPANY AND REGULATORY RESTRICTIONS (Condensed Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities        
Net income   $ 58,669 $ 73,928 $ 79,894
Adjustments to reconcile net income to net cash provided by operating activities:        
Deferred income tax (benefit) expense   11,211 25,810 10,828
Share-based compensation expense   1,636 3,273 3,231
Net Cash Provided by (Used in) Investing Activities [Abstract]        
Proceeds from sale of investment securities $ 28,100     279,500
Net return of capital from unconsolidated entities   495 0 0
Cash flows from financing activities:        
Net proceeds from issuance of common stock and stock option exercises   0 679 1,236
Repurchases of common stock   (2,632) (20,740) (18,669)
Cash dividends paid on common stock   (28,117) (28,505) (26,959)
Cash and cash equivalents at beginning of year   112,044 328,907 104,067
Cash and cash equivalents at end of year 522,437 522,437 112,044 328,907
Parent        
Cash flows from operating activities        
Net income   58,669 73,928 79,894
Adjustments to reconcile net income to net cash provided by operating activities:        
Deferred income tax (benefit) expense   32 (26) 70
Equity in undistributed income of subsidiary bank   (23,396) (31,764) (31,465)
Share-based compensation expense   1,636 3,273 3,231
Net change in other assets and liabilities   (1,543) (20) (85)
Net cash provided by operating activities   35,398 45,391 51,645
Net Cash Provided by (Used in) Investing Activities [Abstract]        
Proceeds from sale of investment securities   0 0 1,653
Net return of capital from unconsolidated entities   495 0 0
Net cash provided by investing activities   495 0 1,653
Cash flows from financing activities:        
Net proceeds from issuance of common stock and stock option exercises   0 679 1,236
Repurchases of common stock   (2,632) (20,740) (18,669)
Cash dividends paid on common stock   (28,117) (28,505) (26,959)
Net cash used in financing activities   (30,749) (48,566) (44,392)
Net increase (decrease) in cash and cash equivalents   5,144 (3,175) 8,906
Cash and cash equivalents at beginning of year   16,915 20,090 11,184
Cash and cash equivalents at end of year $ 22,059 $ 22,059 $ 16,915 $ 20,090